A recent study identifies WNT2 as a key promoter of CRC progression through its role in enhancing myeloid-derived suppressor cells accumulation and immunosuppression via the p38 MAPK/Akt pathway. This evidence concerns the gene AKT1 and colorectal carcinoma.